Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Total article views   HTML views PDF downloads Totals
9,189 Dovepress* 7,624+ 1,758 9,382
PubMed Central* 1,565 582 2,147
Totals 9,189 2,340 11,529
*Since 24 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 1 4

View citations on PubMed Central and Google Scholar